nodes	percent_of_prediction	percent_of_DWPC	metapath
Glucosamine—IFNG—rheumatoid arthritis	0.212	0.486	CbGaD
Glucosamine—osteoarthritis—Prednisone—rheumatoid arthritis	0.19	0.5	CpDpCtD
Glucosamine—osteoarthritis—Methylprednisolone—rheumatoid arthritis	0.19	0.5	CpDpCtD
Glucosamine—MMP9—rheumatoid arthritis	0.135	0.31	CbGaD
Glucosamine—TNF—rheumatoid arthritis	0.0888	0.204	CbGaD
Glucosamine—MMP9—synovial fluid—rheumatoid arthritis	0.00864	0.211	CbGeAlD
Glucosamine—IFNG—synovial membrane of synovial joint—rheumatoid arthritis	0.00661	0.162	CbGeAlD
Glucosamine—MMP9—skeletal joint—rheumatoid arthritis	0.00559	0.137	CbGeAlD
Glucosamine—MMP9—cartilage tissue—rheumatoid arthritis	0.00376	0.092	CbGeAlD
Glucosamine—IFNG—exocrine gland—rheumatoid arthritis	0.00318	0.0778	CbGeAlD
Glucosamine—CYP2C19—Prednisone—rheumatoid arthritis	0.00206	0.28	CbGbCtD
Glucosamine—CYP2E1—Dexamethasone—rheumatoid arthritis	0.00205	0.279	CbGbCtD
Glucosamine—CYP2C19—Cyclosporine—rheumatoid arthritis	0.00195	0.266	CbGbCtD
Glucosamine—NFKB2—lymphoid tissue—rheumatoid arthritis	0.00157	0.0384	CbGeAlD
Glucosamine—NFKB2—digestive system—rheumatoid arthritis	0.00155	0.038	CbGeAlD
Glucosamine—NFKB2—tendon—rheumatoid arthritis	0.00148	0.0361	CbGeAlD
Glucosamine—IFNG—connective tissue—rheumatoid arthritis	0.00146	0.0356	CbGeAlD
Glucosamine—CYP2C19—Dexamethasone—rheumatoid arthritis	0.00129	0.175	CbGbCtD
Glucosamine—IFNG—lymphoid tissue—rheumatoid arthritis	0.00106	0.0261	CbGeAlD
Glucosamine—IFNG—digestive system—rheumatoid arthritis	0.00105	0.0257	CbGeAlD
Glucosamine—IFNG—tendon—rheumatoid arthritis	0.001	0.0245	CbGeAlD
Glucosamine—MMP9—connective tissue—rheumatoid arthritis	0.000935	0.0229	CbGeAlD
Glucosamine—Vidarabine—DPP4—rheumatoid arthritis	0.000927	0.556	CrCbGaD
Glucosamine—Adenosine—DPP4—rheumatoid arthritis	0.000741	0.444	CrCbGaD
Glucosamine—MMP9—lymphoid tissue—rheumatoid arthritis	0.000683	0.0167	CbGeAlD
Glucosamine—MMP9—digestive system—rheumatoid arthritis	0.000675	0.0165	CbGeAlD
Glucosamine—MMP9—tendon—rheumatoid arthritis	0.000642	0.0157	CbGeAlD
Glucosamine—CYP2C19—digestive system—rheumatoid arthritis	0.000303	0.00741	CbGeAlD
Glucosamine—CYP2E1—lymphoid tissue—rheumatoid arthritis	0.000225	0.00551	CbGeAlD
Glucosamine—CYP2E1—digestive system—rheumatoid arthritis	0.000222	0.00545	CbGeAlD
Glucosamine—NFKB2—Dexamethasone—Hydrocortisone—rheumatoid arthritis	0.00022	0.0912	CbGdCrCtD
Glucosamine—NFKB2—Betamethasone—Hydrocortisone—rheumatoid arthritis	0.00022	0.0912	CbGdCrCtD
Glucosamine—CYP2E1—tendon—rheumatoid arthritis	0.000212	0.00518	CbGeAlD
Glucosamine—NFKB2—Betamethasone—Methylprednisolone—rheumatoid arthritis	0.000208	0.0861	CbGdCrCtD
Glucosamine—NFKB2—Dexamethasone—Methylprednisolone—rheumatoid arthritis	0.000208	0.0861	CbGdCrCtD
Glucosamine—NFKB2—Dexamethasone—Betamethasone—rheumatoid arthritis	0.000205	0.0847	CbGdCrCtD
Glucosamine—NFKB2—Betamethasone—Dexamethasone—rheumatoid arthritis	0.000205	0.0847	CbGdCrCtD
Glucosamine—NFKB2—Betamethasone—Triamcinolone—rheumatoid arthritis	0.0002	0.0828	CbGdCrCtD
Glucosamine—NFKB2—Dexamethasone—Triamcinolone—rheumatoid arthritis	0.0002	0.0828	CbGdCrCtD
Glucosamine—NFKB2—Dexamethasone—Prednisone—rheumatoid arthritis	0.00019	0.0786	CbGdCrCtD
Glucosamine—NFKB2—Betamethasone—Prednisone—rheumatoid arthritis	0.00019	0.0786	CbGdCrCtD
Glucosamine—NFKB2—Dexamethasone—Prednisolone—rheumatoid arthritis	0.000185	0.0767	CbGdCrCtD
Glucosamine—NFKB2—Betamethasone—Prednisolone—rheumatoid arthritis	0.000185	0.0767	CbGdCrCtD
Glucosamine—IFNG—Immune System—CD28—rheumatoid arthritis	1.29e-05	9.78e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Arachidonic acid metabolism—PTGS2—rheumatoid arthritis	1.29e-05	9.77e-05	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—IL6R—rheumatoid arthritis	1.28e-05	9.74e-05	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—IL6—rheumatoid arthritis	1.28e-05	9.74e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—PTPRC—rheumatoid arthritis	1.27e-05	9.61e-05	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—MMP9—rheumatoid arthritis	1.27e-05	9.6e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—VCAM1—rheumatoid arthritis	1.26e-05	9.59e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL1RN—rheumatoid arthritis	1.26e-05	9.56e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—HLA-DQA1—rheumatoid arthritis	1.26e-05	9.56e-05	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—IL6—rheumatoid arthritis	1.25e-05	9.49e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PDE2A—rheumatoid arthritis	1.24e-05	9.39e-05	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—CXCL8—rheumatoid arthritis	1.23e-05	9.31e-05	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—MMP2—rheumatoid arthritis	1.23e-05	9.3e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—HLA-DPB1—rheumatoid arthritis	1.22e-05	9.28e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—UBE2D1—rheumatoid arthritis	1.21e-05	9.21e-05	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—TYK2—rheumatoid arthritis	1.2e-05	9.11e-05	CbGpPWpGaD
Glucosamine—TNF—Alzheimers Disease—TP53—rheumatoid arthritis	1.18e-05	8.98e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PLB1—rheumatoid arthritis	1.18e-05	8.96e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—HLA-DQB1—rheumatoid arthritis	1.18e-05	8.95e-05	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—IL1B—rheumatoid arthritis	1.18e-05	8.93e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—ADRBK1—rheumatoid arthritis	1.18e-05	8.93e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CD40—rheumatoid arthritis	1.18e-05	8.93e-05	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—TYK2—rheumatoid arthritis	1.17e-05	8.87e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CTLA4—rheumatoid arthritis	1.16e-05	8.8e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—HMGB1—rheumatoid arthritis	1.16e-05	8.8e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—PTPRC—rheumatoid arthritis	1.14e-05	8.67e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—PTK2—rheumatoid arthritis	1.14e-05	8.65e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—rheumatoid arthritis	1.13e-05	8.58e-05	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—TP53—rheumatoid arthritis	1.13e-05	8.55e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL1A—rheumatoid arthritis	1.12e-05	8.5e-05	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—CXCL8—rheumatoid arthritis	1.12e-05	8.49e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL18—rheumatoid arthritis	1.12e-05	8.48e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CD40LG—rheumatoid arthritis	1.11e-05	8.45e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—IL6—rheumatoid arthritis	1.11e-05	8.44e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—RASGRP1—rheumatoid arthritis	1.11e-05	8.42e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CD79A—rheumatoid arthritis	1.11e-05	8.4e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—SYK—rheumatoid arthritis	1.11e-05	8.4e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CD8A—rheumatoid arthritis	1.1e-05	8.35e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CSF2—rheumatoid arthritis	1.1e-05	8.35e-05	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—NFKB1—rheumatoid arthritis	1.1e-05	8.33e-05	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—LEP—rheumatoid arthritis	1.09e-05	8.3e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—RBPJ—rheumatoid arthritis	1.09e-05	8.27e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—PRKCQ—rheumatoid arthritis	1.09e-05	8.24e-05	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—CD4—rheumatoid arthritis	1.09e-05	8.24e-05	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—MAPK8—rheumatoid arthritis	1.08e-05	8.19e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—ADIPOQ—rheumatoid arthritis	1.08e-05	8.18e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—AGER—rheumatoid arthritis	1.07e-05	8.15e-05	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—IL1B—rheumatoid arthritis	1.07e-05	8.14e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—STAT1—rheumatoid arthritis	1.07e-05	8.1e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	1.06e-05	8.06e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—HLA-B—rheumatoid arthritis	1.06e-05	8.04e-05	CbGpPWpGaD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—IL6—rheumatoid arthritis	1.05e-05	7.94e-05	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—TGFB1—rheumatoid arthritis	1.04e-05	7.91e-05	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—IL6ST—rheumatoid arthritis	1.03e-05	7.79e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—VCAM1—rheumatoid arthritis	1.02e-05	7.77e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—HLA-DQA1—rheumatoid arthritis	1.02e-05	7.75e-05	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—IL1B—rheumatoid arthritis	1.01e-05	7.67e-05	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—NFKB1—rheumatoid arthritis	1e-05	7.6e-05	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—IL6—rheumatoid arthritis	9.93e-06	7.54e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL2RA—rheumatoid arthritis	9.92e-06	7.53e-05	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—MAPK8—rheumatoid arthritis	9.89e-06	7.51e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—C3—rheumatoid arthritis	9.84e-06	7.47e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—HLA-A—rheumatoid arthritis	9.81e-06	7.44e-05	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—rheumatoid arthritis	9.81e-06	7.44e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—PRKCQ—rheumatoid arthritis	9.8e-06	7.43e-05	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—TGFB1—rheumatoid arthritis	9.65e-06	7.32e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CXCL13—rheumatoid arthritis	9.63e-06	7.3e-05	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—IL6—rheumatoid arthritis	9.59e-06	7.28e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—HLA-DQB1—rheumatoid arthritis	9.55e-06	7.25e-05	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—NFKB1—rheumatoid arthritis	9.43e-06	7.16e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	9.38e-06	7.12e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	9.38e-06	7.12e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CRP—rheumatoid arthritis	9.36e-06	7.1e-05	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—NFKB1—rheumatoid arthritis	9.35e-06	7.1e-05	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—MAPK8—rheumatoid arthritis	9.27e-06	7.04e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—PTK2—rheumatoid arthritis	9.23e-06	7.01e-05	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—MAPK8—rheumatoid arthritis	9.19e-06	6.98e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—FADS2—rheumatoid arthritis	9.19e-06	6.97e-05	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—IL6R—rheumatoid arthritis	9.16e-06	6.95e-05	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—VEGFA—rheumatoid arthritis	9.09e-06	6.89e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL1A—rheumatoid arthritis	9.07e-06	6.88e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL18—rheumatoid arthritis	9.05e-06	6.87e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CD40LG—rheumatoid arthritis	9.02e-06	6.84e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—TLR4—rheumatoid arthritis	8.97e-06	6.81e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—HLA-DRB1—rheumatoid arthritis	8.96e-06	6.8e-05	CbGpPWpGaD
Glucosamine—MMP9—Extracellular matrix organization—TGFB1—rheumatoid arthritis	8.94e-06	6.79e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CD8A—rheumatoid arthritis	8.92e-06	6.77e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CSF2—rheumatoid arthritis	8.92e-06	6.77e-05	CbGpPWpGaD
Glucosamine—TNF—Toll-like Receptor Signaling Pathway—IL6—rheumatoid arthritis	8.83e-06	6.7e-05	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—MMP2—rheumatoid arthritis	8.74e-06	6.64e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	8.72e-06	6.62e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—AGER—rheumatoid arthritis	8.7e-06	6.6e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IRAK1—rheumatoid arthritis	8.67e-06	6.58e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TLE3—rheumatoid arthritis	8.67e-06	6.58e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—ICAM1—rheumatoid arthritis	8.6e-06	6.53e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL6ST—rheumatoid arthritis	8.6e-06	6.53e-05	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—TP53—rheumatoid arthritis	8.58e-06	6.51e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—HLA-B—rheumatoid arthritis	8.58e-06	6.51e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CX3CR1—rheumatoid arthritis	8.58e-06	6.51e-05	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—NFKB1—rheumatoid arthritis	8.51e-06	6.46e-05	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—IL6—rheumatoid arthritis	8.48e-06	6.44e-05	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—MAPK8—rheumatoid arthritis	8.37e-06	6.35e-05	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—TYK2—rheumatoid arthritis	8.35e-06	6.33e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—PTK2—rheumatoid arthritis	8.33e-06	6.32e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CD80—rheumatoid arthritis	8.28e-06	6.28e-05	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—VEGFA—rheumatoid arthritis	8.27e-06	6.28e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IL2RB—rheumatoid arthritis	8.26e-06	6.27e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL2RA—rheumatoid arthritis	8.04e-06	6.1e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—C5—rheumatoid arthritis	7.98e-06	6.05e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—C3—rheumatoid arthritis	7.97e-06	6.05e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—HLA-A—rheumatoid arthritis	7.95e-06	6.03e-05	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—TGFB1—rheumatoid arthritis	7.86e-06	5.96e-05	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—IL6—rheumatoid arthritis	7.86e-06	5.96e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NFATC1—rheumatoid arthritis	7.85e-06	5.95e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Biological oxidations—POMC—rheumatoid arthritis	7.79e-06	5.91e-05	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—rheumatoid arthritis	7.73e-06	5.86e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL6R—rheumatoid arthritis	7.68e-06	5.82e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	7.65e-06	5.8e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CRP—rheumatoid arthritis	7.58e-06	5.75e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCR6—rheumatoid arthritis	7.5e-06	5.69e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NCF2—rheumatoid arthritis	7.29e-06	5.54e-05	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—IL6—rheumatoid arthritis	7.27e-06	5.52e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—TLR4—rheumatoid arthritis	7.27e-06	5.52e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—HLA-DRB1—rheumatoid arthritis	7.26e-06	5.51e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TRAF6—rheumatoid arthritis	7.11e-06	5.39e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—SH2B3—rheumatoid arthritis	7.11e-06	5.39e-05	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	7.09e-06	5.38e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—FADS2—rheumatoid arthritis	7.09e-06	5.38e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—GZMB—rheumatoid arthritis	7.06e-06	5.36e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—TYK2—rheumatoid arthritis	6.99e-06	5.3e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL6ST—rheumatoid arthritis	6.97e-06	5.29e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—ICAM1—rheumatoid arthritis	6.97e-06	5.29e-05	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—TP53—rheumatoid arthritis	6.9e-06	5.24e-05	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—IL6—rheumatoid arthritis	6.89e-06	5.23e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CXCL2—rheumatoid arthritis	6.86e-06	5.2e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCL3—rheumatoid arthritis	6.86e-06	5.2e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CD80—rheumatoid arthritis	6.71e-06	5.09e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—SAA1—rheumatoid arthritis	6.71e-06	5.09e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—LEP—rheumatoid arthritis	6.69e-06	5.08e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NCF1—rheumatoid arthritis	6.57e-06	4.98e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IFNG—rheumatoid arthritis	6.55e-06	4.97e-05	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—NFKB1—rheumatoid arthritis	6.5e-06	4.93e-05	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—TP53—rheumatoid arthritis	6.47e-06	4.91e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CD4—rheumatoid arthritis	6.32e-06	4.8e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CD28—rheumatoid arthritis	6.32e-06	4.79e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—IL6ST—rheumatoid arthritis	6.29e-06	4.77e-05	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—IL6—rheumatoid arthritis	6.28e-06	4.77e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL6R—rheumatoid arthritis	6.22e-06	4.72e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PLD4—rheumatoid arthritis	6.13e-06	4.65e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Biological oxidations—POMC—rheumatoid arthritis	6.01e-06	4.56e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—UBE2D1—rheumatoid arthritis	5.95e-06	4.51e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ACAN—rheumatoid arthritis	5.92e-06	4.49e-05	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—VEGFA—rheumatoid arthritis	5.9e-06	4.48e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	5.89e-06	4.47e-05	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—IL6—rheumatoid arthritis	5.87e-06	4.45e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL1B—rheumatoid arthritis	5.84e-06	4.43e-05	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	5.84e-06	4.43e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CXCL12—rheumatoid arthritis	5.83e-06	4.43e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—BDKRB2—rheumatoid arthritis	5.83e-06	4.43e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL2—rheumatoid arthritis	5.82e-06	4.41e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—ADRBK1—rheumatoid arthritis	5.77e-06	4.38e-05	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—IL6—rheumatoid arthritis	5.72e-06	4.34e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—TYK2—rheumatoid arthritis	5.66e-06	4.3e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—IL6R—rheumatoid arthritis	5.61e-06	4.26e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—SLC25A12—rheumatoid arthritis	5.57e-06	4.22e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—NFKB1—rheumatoid arthritis	5.45e-06	4.13e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—RASGRP1—rheumatoid arthritis	5.44e-06	4.13e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—SYK—rheumatoid arthritis	5.42e-06	4.11e-05	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—TGFB1—rheumatoid arthritis	5.42e-06	4.11e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—GC—rheumatoid arthritis	5.41e-06	4.11e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PTGES—rheumatoid arthritis	5.41e-06	4.11e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—MAPK8—rheumatoid arthritis	5.35e-06	4.06e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—MMP2—rheumatoid arthritis	5.35e-06	4.06e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PRKCQ—rheumatoid arthritis	5.32e-06	4.04e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—STAT1—rheumatoid arthritis	5.23e-06	3.97e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CXCL10—rheumatoid arthritis	5.15e-06	3.91e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CD4—rheumatoid arthritis	5.12e-06	3.89e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—TYK2—rheumatoid arthritis	5.11e-06	3.88e-05	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—TNF—rheumatoid arthritis	5.06e-06	3.84e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PLB1—rheumatoid arthritis	5.03e-06	3.82e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL1B—rheumatoid arthritis	4.73e-06	3.59e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PLD4—rheumatoid arthritis	4.73e-06	3.59e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL2—rheumatoid arthritis	4.71e-06	3.58e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—MMP3—rheumatoid arthritis	4.7e-06	3.57e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ACAN—rheumatoid arthritis	4.57e-06	3.47e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PTK2—rheumatoid arthritis	4.52e-06	3.43e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCL5—rheumatoid arthritis	4.44e-06	3.37e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—MED1—rheumatoid arthritis	4.41e-06	3.35e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—NFKB1—rheumatoid arthritis	4.41e-06	3.35e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CSF2—rheumatoid arthritis	4.37e-06	3.32e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—MAPK8—rheumatoid arthritis	4.34e-06	3.29e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—SLC25A12—rheumatoid arthritis	4.29e-06	3.26e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PTGES—rheumatoid arthritis	4.18e-06	3.17e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—GC—rheumatoid arthritis	4.18e-06	3.17e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—SPP1—rheumatoid arthritis	4.11e-06	3.12e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—B3GNT2—rheumatoid arthritis	4.1e-06	3.11e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ACP5—rheumatoid arthritis	4.1e-06	3.11e-05	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—IL6—rheumatoid arthritis	4.08e-06	3.1e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—MMP9—rheumatoid arthritis	4.02e-06	3.05e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCR5—rheumatoid arthritis	4e-06	3.03e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—NFKB1—rheumatoid arthritis	3.98e-06	3.02e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IL2RA—rheumatoid arthritis	3.94e-06	2.99e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—C3—rheumatoid arthritis	3.91e-06	2.96e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PLB1—rheumatoid arthritis	3.88e-06	2.95e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—BGN—rheumatoid arthritis	3.69e-06	2.8e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—LEP—rheumatoid arthritis	3.64e-06	2.76e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—VEGFA—rheumatoid arthritis	3.61e-06	2.74e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—FN1—rheumatoid arthritis	3.43e-06	2.6e-05	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—IL6—rheumatoid arthritis	3.42e-06	2.59e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IL6ST—rheumatoid arthritis	3.42e-06	2.59e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—MED1—rheumatoid arthritis	3.41e-06	2.58e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ALOX5—rheumatoid arthritis	3.4e-06	2.58e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—TGFB1—rheumatoid arthritis	3.32e-06	2.52e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CD80—rheumatoid arthritis	3.29e-06	2.49e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ACP5—rheumatoid arthritis	3.17e-06	2.4e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—B3GNT2—rheumatoid arthritis	3.17e-06	2.4e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—POMC—rheumatoid arthritis	3.12e-06	2.37e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CCL2—rheumatoid arthritis	3.06e-06	2.32e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IL6R—rheumatoid arthritis	3.05e-06	2.31e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—BGN—rheumatoid arthritis	2.85e-06	2.16e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TYK2—rheumatoid arthritis	2.78e-06	2.11e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ENO1—rheumatoid arthritis	2.77e-06	2.1e-05	CbGpPWpGaD
Glucosamine—IFNG—Immune System—IL6—rheumatoid arthritis	2.77e-06	2.1e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NOS3—rheumatoid arthritis	2.72e-06	2.07e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ALOX5—rheumatoid arthritis	2.62e-06	1.99e-05	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—IL6—rheumatoid arthritis	2.5e-06	1.9e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CXCL8—rheumatoid arthritis	2.42e-06	1.83e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IL2—rheumatoid arthritis	2.31e-06	1.75e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	2.31e-06	1.75e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—NFKB1—rheumatoid arthritis	2.16e-06	1.64e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ENO1—rheumatoid arthritis	2.14e-06	1.62e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—MAPK8—rheumatoid arthritis	2.13e-06	1.61e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	2.1e-06	1.6e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CAT—rheumatoid arthritis	2e-06	1.51e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—VEGFA—rheumatoid arthritis	1.96e-06	1.49e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.84e-06	1.4e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TGFB1—rheumatoid arthritis	1.8e-06	1.37e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—MTHFR—rheumatoid arthritis	1.67e-06	1.26e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CAT—rheumatoid arthritis	1.54e-06	1.17e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TP53—rheumatoid arthritis	1.48e-06	1.13e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IL6—rheumatoid arthritis	1.36e-06	1.03e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—POMC—rheumatoid arthritis	1.33e-06	1.01e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—MTHFR—rheumatoid arthritis	1.28e-06	9.75e-06	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—ALB—rheumatoid arthritis	1.21e-06	9.21e-06	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—NOS3—rheumatoid arthritis	1.16e-06	8.81e-06	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PTGS2—rheumatoid arthritis	1.06e-06	8.06e-06	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—POMC—rheumatoid arthritis	1.03e-06	7.8e-06	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—ALB—rheumatoid arthritis	9.37e-07	7.11e-06	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—NOS3—rheumatoid arthritis	8.96e-07	6.8e-06	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PTGS2—rheumatoid arthritis	8.19e-07	6.22e-06	CbGpPWpGaD
